Healthy Volunteer clinical trials
123 active trials name this condition. Describe your situation to see which ones you may be eligible for.
By location
- Single Dose Study, Pharmacokinetics of Oxycodone and PF614 Co-Administered With Nafamostat (PF614-MPAR-102)
- A First in Human Study of the Safety, Tolerability, and the Physiologically Based Pharmacokinetics of XFB19 in Healthy Adult Volunteers.
- Neuropharmacologic Imaging and Biomarker Assessments of Response to Acute and Repeated-Dosed Ketamine Infusions in Major Depressive Disorder
- Drug-drug Interaction Study of Bemnifosbuvir/Ruzasvir (BEM/RZR) and Buprenorphine/Naloxone or Methadone
- Exploratory Clinical Study to Assess Safety and Efficacy of Xenon Gas Inhalation to Control Neuroinflammation
- Safety and PK of Ceftibuten-ledaborbactam Etzadroxil Fixed-dose Combination
- Randomized, Open-label, Safety Study of Subcutaneous and Intramuscular Injections of Niagen® Plus
- Dose Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics And Pharmacodynamics of SIF001 in Healthy Subjects and in Epilepsy Patients
- Neutralizing Interleukin (IL)-6
- Study of XmAb942 in Healthy Participants and Participants With Ulcerative Colitis
- A Phase 1 Study of the Safety and How the Body Processes ABBV-722 and Upadacitinib After Multiple Oral Doses in Healthy Adult Participants
- S-Nitrosylation (SNO) Therapy During Autologous Blood Transfusion
- A Study to Learn About the Safety of BIIB142 and How it is Processed in the Body of Healthy Adult Participants Aged 18 to 55 Years Old
- A Study to Learn More About the Safety of BIIB145 and How it is Processed in the Body of Healthy Adult Participants
- First-in-Human Study of VNT-101: Safety, Tolerability, and Pharmacokinetics
- Study About Whether Atirmociclib/PF-07220060 Proportionally Increases Exposure as Dose Increases in Healthy Participants
- Safety and Tolerability Trial of Psilocybin in Healthy Older Adults
- A Study of ORX489 in Healthy Adult Participants, Aged 18 to 60 Years
- Home Sleep Therapy for Older Adults With MCI
- Nalmefene Implant in Healthy Subjects
- A Study to Evaluate the Effect of Food on the Bioavailability of AJ201, and Safety, Tolerability, and Pharmacokinetics of AJ201 in Japanese and White Healthy Male Participants
- Neurofeedback Intervention for Reading Deficits in Subacute Stroke
- Cardiometabolic Benefit of Reducing Iatrogenic Hyperinsulinemia Using Insulin Adjunctive Therapy in Type 1 Diabetes
- Safety and Immunogenicity of Ad4-HIV Envelope Vaccine Vectors in Healthy Volunteers
- PET Imaging of Radiolabeled Anti-HIV-1 Envelope Monoclonal Antibody (VRC01)
- Acute Effects of Alcohol on PET Imaging of Phosphodiesterase-4B (PDE4B)
- PET Imaging of Cyclooxygenase in Participants With Major Depressive Disorder (MDD)
- [18F]PF-06445974 to Image PDE4B in Major Depressive Disorder Using PET
- Positron Emission Tomography (PET) Contrast Agent Kinetics and Safety: [18F]-Fluoromannitol
- Non-Invasive Respiratory Monitor
- Ultralow Dose PET Imaging of 18F-FDG Uptake
- Ultralow Dose PET Imaging for 18F-NaF Uptake
- A Study to Learn More About the Safety of a Single Dose of BIIB144 and How it is Processed in the Body of Healthy Adult Participants Ages 18 to 55 Years Old as Compared to a Placebo
- A Study to Evaluate How Multiple Doses of Itraconazole Interacts With Nacresertib in Healthy Adult Participants
- Studies of Blood Flow to the Brain During Thought
- Magnetic Resonance Imaging (MRI) to Evaluate Activity of Multiple Sclerosis (MS)
- Normative Data for Sweating Rate, Sweat Sodium Concentration and Sweat Sodium Loss in Female Athlete
- Development and Validation of Learning and Decision-Making Tasks
- Collection of Bone Marrow Aspirate From Normal Volunteers
- Recruitment and Characterization of Healthy Research Volunteers for NIMH Intramural Studies
- Collection of Peripheral Blood Mononuclear Cells (PBMCs) From Healthy People for the Expansion of T Cells for Adoptive Cell Therapy
- Normal Values in Hearing and Balance Testing
- Brain Stimulation and Vision Testing
- Study of the Effect of Innate on the Inflammatory Response to Endotoxin
- Imaging Techniques in MRI
- Top-Down Attentional Control of Visual-Processing
- VRC 900: Evaluation of Tissue-Specific Immune Responses in Adults 18 Years of Age and Older
- Development of Magnetic Resonance Imaging Techniques for Studying Mood and Anxiety Disorders
- Collection of Data and Samples From Healthy Donors for Use in Translational Research
- Urinary Vitamin C Loss in Diabetic Subjects
Guides for people searching for a trial
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.
Showing active trials that list “Healthy Volunteer” as a condition. Eligibility shown on each trial is an estimate — the trial's study team makes the final decision.